Generic Product Pipeline
Various (across ~80 product families)
ANDA Development/SubmissionActive
Key Facts
Indication
Various (across ~80 product families)
Phase
ANDA Development/Submission
Status
Active
Company
About Par Health
Par Health is a US-based, commercial-stage pharmaceutical company specializing in generic drugs, APIs, and sterile injectables. Formed in 2019 from the merger of Mallinckrodt and Endo, it leverages a robust, vertically integrated manufacturing footprint across 10 sites in the US and India. With a portfolio of approximately 200 products and over 50 in development, the company aims to provide affordable, essential medicines globally, supported by over 4,000 employees. Its business model is centered on reliable supply, quality manufacturing, and cost-effective therapeutics.
View full company profile